Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares changing hands. The stock had previously closed at $24.02. Analyst Ratings Changes MIRM has been the […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) SVP Jolanda Howe sold 528 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $28.04, for a total transaction of $14,805.12. Following the completion of the transaction, the senior vice president now directly […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by investment analysts at JMP Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $64.00 price objective on the stock. JMP Securities’ price objective points to a potential upside of 142.15% from […]
Brown Brothers Harriman & Co. purchased a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 1,194 shares of the company’s stock, valued at approximately $31,000. Several other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $31.00, but opened at $32.28. Mirum Pharmaceuticals shares last traded at $32.35, with a volume of 70,778 shares changing hands. Analyst Upgrades and Downgrades Several equities analysts recently commented on MIRM […]